Executive Summary
Healthcare AI is no longer one technology. It is a toolkit. Some products help radiologists find urgent findings faster. Some draft clinical notes. Others route patients, monitor high-risk people at home, detect sepsis risk, optimize operating rooms, reduce claim denials, or speed drug discovery.
Most mature today
Radiology, medical imaging, diabetic eye screening, and selected FDA-cleared diagnostic tools have the strongest regulatory track record.
Fastest adoption
Ambient clinical documentation is spreading quickly because it saves clinician time, reduces after-hours charting, and integrates into EHR workflows.
Best CIO lens
Evaluate AI by safety, evidence, workflow fit, interoperability, privacy, model monitoring, user adoption, and total cost of change management.
Radiology AI
Clinical documentation
Patient access
Hospital operations
Remote monitoring
Revenue cycle
Drug discovery
Simple Explanation of AI in Healthcare
AI in healthcare means software that learns patterns from data and helps people make faster, more consistent decisions. It can read images, summarize conversations, predict patient risk, automate routine work, or suggest next steps. Good healthcare AI should support trained professionals. It should not silently replace clinical judgment.
How to read the FDA field
In the United States, many AI medical devices are FDA-cleared or De Novo authorized, not formally "approved" in the drug-style sense. In this report, Yes means an FDA clearance, authorization, or credible official regulatory source was found. Not Applicable means the product is mainly administrative, documentation, engagement, operations, or research software. Not Found means no clear U.S. FDA status was found during this review.
Aidoc aiOS
FDA: Yes
- Specialized Area
- Radiology triage, care coordination, incidental findings, enterprise clinical AI.
- Pricing / Trial
- Enterprise subscription; public pricing not listed. Request demo / contact sales.
- Use Case in Healthcare
- Flags possible urgent findings on CT/X-ray and routes alerts to radiology and care teams.
- FDA Approved
- Yes - FDA-cleared algorithms/platform components reported.
- Rating or Market Reputation
- Large FDA-cleared portfolio; reported 2026 Series E funding and strong radiology market visibility.
- Short Benefits
- Faster triage, fewer missed handoffs, cross-specialty workflow support.
- Limitations or Caution
- Needs local validation, radiologist oversight, alert governance, and workflow tuning.
- Best Suited For
- Hospitals, radiology groups, emergency departments, and multi-site health systems.
Sources: Official | FDA AI-enabled devices list | Axios market update
Viz.ai
FDA: Yes
- Specialized Area
- AI-powered care pathways for stroke, vascular, cardiac, pulmonary, trauma, and care coordination.
- Pricing / Trial
- Enterprise contract; pricing not public. Demo / sales consultation.
- Use Case in Healthcare
- Detects suspected time-sensitive conditions and coordinates specialists via alerts and mobile workflow.
- FDA Approved
- Yes - FDA-cleared solutions reported by vendor.
- Rating or Market Reputation
- Known for stroke and care-team activation; vendor reports 50+ FDA-cleared AI-powered solutions.
- Short Benefits
- Speeds specialist notification, reduces treatment delays, connects distributed teams.
- Limitations or Caution
- Can create alert fatigue if thresholds and escalation rules are not managed.
- Best Suited For
- Stroke networks, comprehensive stroke centers, trauma centers, and large hospitals.
Sources: Official | Viz.ai care pathways
RapidAI
FDA: Yes
- Specialized Area
- Neurovascular imaging, stroke workflows, aneurysm, pulmonary embolism, and related clinical AI modules.
- Pricing / Trial
- Enterprise licensing; public pricing not listed.
- Use Case in Healthcare
- Supports stroke imaging interpretation, LVO detection, perfusion analysis, and team notification.
- FDA Approved
- Yes - multiple FDA-cleared modules reported.
- Rating or Market Reputation
- Vendor reports use in 2,500+ hospitals across 100+ countries and a deep clinical publication base.
- Short Benefits
- Improves speed and consistency in stroke triage and transfer decisions.
- Limitations or Caution
- Performance depends on imaging quality, protocol standardization, and local stroke workflow.
- Best Suited For
- Stroke centers, emergency departments, neurologists, neurointerventional teams.
Sources: Official | RapidAI Stroke | FDA clearance news
Qure.ai
FDA: Yes
- Specialized Area
- Chest X-ray, head CT, tuberculosis, lung nodule, stroke, and emergency imaging AI.
- Pricing / Trial
- Enterprise deployment; pricing usually by geography, volume, and product suite.
- Use Case in Healthcare
- Screening and triage support for radiology workflows, public health, and emergency reads.
- FDA Approved
- Yes - multiple U.S. FDA 510(k) clearances listed by vendor.
- Rating or Market Reputation
- Strong global health presence; vendor reports continuing U.S. growth and multiple clearances.
- Short Benefits
- Useful for high-volume screening, rural access, TB programs, and urgent CT/X-ray triage.
- Limitations or Caution
- Must validate population fit; screening tools can perform differently across sites and devices.
- Best Suited For
- Radiology departments, public health programs, emergency care, and teleradiology networks.
Sources: Official | Regulatory and privacy
Lunit INSIGHT
FDA: Yes
- Specialized Area
- AI for chest X-ray, mammography, breast tomosynthesis, and cancer imaging workflows.
- Pricing / Trial
- Enterprise / distributor pricing; public price not listed.
- Use Case in Healthcare
- Highlights suspicious lesions and supports radiologists in cancer detection and prioritization.
- FDA Approved
- Yes - FDA-cleared products reported, with feature-specific limitations by region.
- Rating or Market Reputation
- Vendor reports products used at 10,000+ sites in 65+ countries.
- Short Benefits
- Can reduce reader fatigue and help standardize cancer detection support.
- Limitations or Caution
- Not a replacement for a radiologist; confirm local regulatory coverage for each feature.
- Best Suited For
- Breast centers, radiology practices, cancer screening programs, imaging networks.
Sources: Official technology page | 2026 breast suite one-pager
HeartFlow FFRCT and Plaque Analysis
FDA: Yes
- Specialized Area
- AI-enabled coronary CT analysis, plaque quantification, and blood-flow modeling.
- Pricing / Trial
- Provider contracts and reimbursement-driven ordering; public pricing not listed.
- Use Case in Healthcare
- Helps assess coronary artery disease from coronary CTA without immediate invasive catheterization.
- FDA Approved
- Yes - FDA-cleared HeartFlow analyses.
- Rating or Market Reputation
- Well-known in cardiac imaging; next-generation plaque platform clearance announced in 2025.
- Short Benefits
- Supports non-invasive CAD evaluation and clearer treatment planning.
- Limitations or Caution
- Requires high-quality CTA and integration with cardiology/radiology pathways.
- Best Suited For
- Cardiology programs, imaging centers, hospitals evaluating stable chest pain pathways.
Sources: Official | FDA clearance news
GE HealthCare Caption AI
FDA: Yes
- Specialized Area
- AI-guided cardiac ultrasound image acquisition and handheld ultrasound workflows.
- Pricing / Trial
- Packaged with compatible ultrasound systems / enterprise purchase; quote-based.
- Use Case in Healthcare
- Guides less-expert users to capture diagnostic-quality cardiac ultrasound images.
- FDA Approved
- Yes - Caption Guidance listed in FDA AI-enabled device materials.
- Rating or Market Reputation
- GE acquired Caption Health; recent Vscan Air integration expands practical access.
- Short Benefits
- Can broaden ultrasound access and reduce dependency on scarce expert sonographers for image capture.
- Limitations or Caution
- Image acquisition support is not a full cardiology diagnosis; training and QA are still required.
- Best Suited For
- Primary care, emergency care, rural clinics, mobile care, and health systems expanding point-of-care ultrasound.
Sources: GE AI ultrasound | Vscan Air Caption AI update | FDA AI devices list
Paige Prostate Suite
FDA: Yes
- Specialized Area
- Digital pathology AI for prostate cancer detection and pathology review support.
- Pricing / Trial
- Enterprise digital pathology licensing; public pricing not listed.
- Use Case in Healthcare
- Assists pathologists reviewing scanned prostate biopsy slides for suspicious cancer foci.
- FDA Approved
- Yes - FDA-authorized / marketed IVD AI pathology product.
- Rating or Market Reputation
- Known as a first FDA-authorized AI pathology product for cancer detection support.
- Short Benefits
- Second-reader support, consistency, workload relief, and digital pathology acceleration.
- Limitations or Caution
- Needs slide scanner compatibility, pathologist oversight, and clear lab validation.
- Best Suited For
- Pathology groups, cancer centers, academic medical centers, digital pathology labs.
Sources: Official clinical page | Paige Prostate
Abridge
FDA: N/A
- Specialized Area
- Ambient clinical documentation, coding context, and clinical conversation intelligence.
- Pricing / Trial
- Enterprise contracts; public pricing not listed. Contact sales.
- Use Case in Healthcare
- Turns patient-clinician conversations into draft notes with linked evidence for review.
- FDA Approved
- Not Applicable - documentation workflow software, not a diagnostic device.
- Rating or Market Reputation
- Named Best in KLAS / market leader for ambient AI in 2025 and 2026 by vendor-reported KLAS results.
- Short Benefits
- Less after-hours charting, faster note completion, stronger clinician experience.
- Limitations or Caution
- Clinicians must verify every note; watch for omissions, wrong context, and coding risk.
- Best Suited For
- Large health systems, outpatient groups, emergency departments, oncology, and multi-specialty networks.
Sources: Official | Best in KLAS 2026 news
Microsoft Dragon Copilot / Nuance DAX Copilot
FDA: N/A
- Specialized Area
- Voice dictation, ambient documentation, clinical workflow assistant, and Microsoft Cloud for Healthcare integration.
- Pricing / Trial
- Enterprise subscription via Microsoft/Nuance; public pricing not clearly listed.
- Use Case in Healthcare
- Creates draft clinical documentation from visits, supports voice commands, and helps automate routine tasks.
- FDA Approved
- Not Applicable - documentation and workflow assistant.
- Rating or Market Reputation
- Microsoft positions Dragon Copilot as a unified voice AI assistant combining dictation and ambient listening.
- Short Benefits
- Deep enterprise footprint, familiar voice workflow, strong EHR and Microsoft ecosystem fit.
- Limitations or Caution
- Enterprise rollout needs privacy review, training, change management, and note QA.
- Best Suited For
- Hospitals and physician groups already using Microsoft/Nuance clinical voice tools.
Sources: Microsoft announcement | DAX Copilot for Epic data sheet
Nabla Copilot
FDA: N/A
- Specialized Area
- Ambient AI medical assistant for clinical note generation across specialties and languages.
- Pricing / Trial
- Homepage offers free trial / free try path; subscription terms indicate monthly user-based licensing.
- Use Case in Healthcare
- Generates structured notes from in-person or telehealth visits and syncs across web, mobile, and extension access.
- FDA Approved
- Not Applicable - documentation assistant.
- Rating or Market Reputation
- Vendor reports broad usage across many care organizations and 30+ supported languages.
- Short Benefits
- Quick setup, multilingual support, useful for smaller practices and larger teams.
- Limitations or Caution
- Generated notes must be reviewed; confirm data residency, BAA, and EHR integration fit.
- Best Suited For
- Clinics, telehealth providers, primary care, specialists, and multilingual care teams.
Sources: Official | Nabla help: what is Nabla? | Subscription terms
Suki Assistant
FDA: N/A
- Specialized Area
- Voice-enabled AI assistant for documentation, commands, pre-charting, and clinical workflow support.
- Pricing / Trial
- Practice / enterprise subscription; public pricing not listed on main site.
- Use Case in Healthcare
- Captures notes, supports editing by voice, and helps clinicians complete documentation inside their workflow.
- FDA Approved
- Not Applicable - documentation and workflow software.
- Rating or Market Reputation
- Vendor reports 400+ leading healthcare systems and partners.
- Short Benefits
- Voice-first workflow, flexible note editing, reduced typing burden.
- Limitations or Caution
- Adoption can lag if clinicians do not trust voice controls or note output quality.
- Best Suited For
- Medical groups and health systems wanting a broad clinician assistant, not only a transcript-to-note tool.
Sources: Official
Ada Assess
FDA: Not Found
- Specialized Area
- AI-powered symptom assessment, care navigation, patient education, and enterprise digital front door.
- Pricing / Trial
- Consumer symptom assessment available online; enterprise partnerships are quote-based.
- Use Case in Healthcare
- Patients answer guided symptom questions and receive information to support next-care decisions.
- FDA Approved
- Not Found for U.S. FDA; Ada reports EU MDR Class IIa certification for enterprise Assess.
- Rating or Market Reputation
- Recognized symptom-assessment brand with enterprise health plan and partner offerings.
- Short Benefits
- 24/7 front-door triage support, less uncertainty for patients, possible call-center relief.
- Limitations or Caution
- Not a replacement for a clinician; escalation rules and local clinical governance are essential.
- Best Suited For
- Health systems, insurers, digital health apps, and patient portals.
Sources: Official | EU MDR certification | Terms and medical disclaimer
Hyro
FDA: N/A
- Specialized Area
- Conversational AI agents for patient access, scheduling, call centers, web chat, and voice automation.
- Pricing / Trial
- Enterprise quote; demo / sales conversation.
- Use Case in Healthcare
- Automates repetitive patient questions, appointment tasks, routing, and call-center workflows.
- FDA Approved
- Not Applicable - administrative and engagement software.
- Rating or Market Reputation
- Healthcare-focused platform used for patient access and operational call-center automation.
- Short Benefits
- Reduces call volume, improves self-service, gives leaders conversational analytics.
- Limitations or Caution
- Needs strong guardrails, handoff to humans, integration with scheduling systems, and HIPAA review.
- Best Suited For
- Hospitals, patient access teams, contact centers, and ambulatory networks.
Sources: Official | Healthcare page
Hippocratic AI
FDA: N/A
- Specialized Area
- Safety-focused patient-facing healthcare agents for non-diagnostic workflows.
- Pricing / Trial
- Book a meeting / enterprise model; public pricing not listed on official site.
- Use Case in Healthcare
- Voice AI agents for outreach, education, adherence, care management, pre-op, discharge, and patient access.
- FDA Approved
- Not Applicable - company states agents do not diagnose or prescribe.
- Rating or Market Reputation
- Vendor reports large safety testing programs, 1,000+ agents, and recognition in AI healthcare lists.
- Short Benefits
- Scalable patient outreach, 24/7 support, built-in escalation concepts.
- Limitations or Caution
- Use only in approved non-diagnostic workflows; monitor calls, adverse events, and escalation safety.
- Best Suited For
- Providers, payers, pharma teams, care management, and patient education programs.
Sources: Official | Safety framework | Polaris model page
Qventus
FDA: N/A
- Specialized Area
- AI operational assistants for surgical growth, perioperative care coordination, inpatient capacity, and hospital operations.
- Pricing / Trial
- Enterprise demo / quote; public pricing not listed.
- Use Case in Healthcare
- Automates administrative tasks, predicts barriers, coordinates workflows, and improves bed/OR throughput.
- FDA Approved
- Not Applicable - operations automation software.
- Rating or Market Reputation
- Vendor reports strong KLAS ratings and recognized hospital operations results.
- Short Benefits
- Better capacity use, fewer cancellations, lower admin burden, faster discharge planning.
- Limitations or Caution
- ROI depends on change management, EHR integration, and frontline adoption.
- Best Suited For
- Hospitals with OR capacity pressure, inpatient bottlenecks, and administrative staffing strain.
Sources: Official | AI operational assistants
LeanTaaS iQueue
FDA: N/A
- Specialized Area
- AI-driven capacity management for operating rooms, infusion centers, surgical clinics, and inpatient flow.
- Pricing / Trial
- SaaS enterprise quote; request demo. Public pricing not listed.
- Use Case in Healthcare
- Optimizes surgical block time, infusion scheduling, staffing, throughput, and patient flow.
- FDA Approved
- Not Applicable - operational analytics software.
- Rating or Market Reputation
- Vendor reports Best in KLAS recognition and use across 190+ health systems.
- Short Benefits
- Higher utilization, shorter waits, better scheduling, improved access and revenue.
- Limitations or Caution
- Requires clean data, process discipline, and leadership commitment.
- Best Suited For
- OR leaders, infusion centers, hospital operations teams, and CIO/COO offices.
Sources: Official | iQueue overview | KLAS page
AKASA
FDA: N/A
- Specialized Area
- Generative AI for healthcare revenue cycle, claims, authorization status, coding, and documentation support.
- Pricing / Trial
- Enterprise contract; public pricing not listed.
- Use Case in Healthcare
- Automates RCM workflows, reduces denials, reviews clinical documentation, and supports staff productivity.
- FDA Approved
- Not Applicable - revenue cycle software.
- Rating or Market Reputation
- Recognized by Black Book as a top AI-powered revenue cycle leader; Cleveland Clinic collaboration announced.
- Short Benefits
- Lower cost-to-collect, faster claim follow-up, less manual work, improved margins.
- Limitations or Caution
- Needs payer-specific testing, audit trails, compliance review, and human exception handling.
- Best Suited For
- Hospital revenue cycle teams, finance leaders, coding, denials, and prior authorization groups.
Sources: Official | Black Book recognition | Press page
Waystar AltitudeAI
FDA: N/A
- Specialized Area
- Healthcare payments, denial appeals, claim intelligence, work queues, and revenue cycle AI.
- Pricing / Trial
- Platform contract; pricing is quote-based.
- Use Case in Healthcare
- Uses generative AI and automation to help providers appeal denials and improve payment workflows.
- FDA Approved
- Not Applicable - healthcare payment software.
- Rating or Market Reputation
- Public healthcare payments company; AltitudeAI launched as a comprehensive AI capability set.
- Short Benefits
- Faster denial appeal drafts, better work prioritization, reduced administrative burden.
- Limitations or Caution
- Appeals and coding decisions need policy review and payer-specific accuracy checks.
- Best Suited For
- Hospitals, physician groups, RCM leaders, and billing teams managing high denial volumes.
Sources: Official | AltitudeAI announcement
Bayesian Health
FDA: Yes
- Specialized Area
- Real-time clinical intelligence and continuous AI monitoring for sepsis and other hospital risks.
- Pricing / Trial
- Enterprise health system platform; pricing not public.
- Use Case in Healthcare
- Continuously monitors EHR signals and flags patients who may need early sepsis evaluation.
- FDA Approved
- Yes - FDA 510(k) clearance announced May 12, 2026 for continuous AI sepsis monitoring.
- Rating or Market Reputation
- Recent FDA milestone; Cleveland Clinic enterprise rollout reported in 2025.
- Short Benefits
- Earlier sepsis detection, lower false alert burden, integrated clinical action workflows.
- Limitations or Caution
- High-risk clinical AI needs ongoing monitoring for drift, bias, adoption, and alert safety.
- Best Suited For
- Hospitals, quality teams, ICU/medicine leaders, sepsis committees, CMIO/CNIO teams.
Sources: Official | FDA clearance announcement | Cleveland Clinic rollout
Digital Diagnostics LumineticsCore
FDA: Yes
- Specialized Area
- Autonomous AI diabetic retinopathy detection in primary care and diabetes clinics.
- Pricing / Trial
- Enterprise / clinic implementation; public pricing not listed. Reimbursement supported by CPT code pathways.
- Use Case in Healthcare
- Captures retinal images and returns an autonomous diagnostic result without specialist review for intended population.
- FDA Approved
- Yes - FDA De Novo-cleared autonomous AI diagnostic system.
- Rating or Market Reputation
- Known as the first FDA De Novo-cleared autonomous AI diagnostic system.
- Short Benefits
- Improves diabetic eye screening access, reduces specialist bottlenecks, supports point-of-care diagnosis.
- Limitations or Caution
- Use only within intended population and image quality requirements; referral protocols are essential.
- Best Suited For
- Primary care groups, diabetes clinics, FQHCs, population health programs.
Sources: Product page | FDA marketing authorization news
DermaSensor
FDA: Yes
- Specialized Area
- AI-powered, non-invasive skin cancer risk assessment device for primary care.
- Pricing / Trial
- Subscription and purchase options; FAQ states no published outright purchase price.
- Use Case in Healthcare
- Provides immediate risk assessment for suspicious skin lesions to support referral decisions.
- FDA Approved
- Yes - FDA-cleared device reported.
- Rating or Market Reputation
- Positioned as first FDA-cleared skin cancer device developed for primary care use.
- Short Benefits
- Point-of-care support, faster referrals, more objective lesion risk assessment.
- Limitations or Caution
- Not for every lesion or patient type; clinical exam and dermatologist referral remain vital.
- Best Suited For
- Primary care, urgent care, dermatology referral networks, rural clinics.
Sources: Official | FAQ and pricing note | FDA De Novo summary
Best Buy Health Current Health
FDA: Yes
- Specialized Area
- Remote patient monitoring, hospital-at-home, chronic care, wearable vital signs, patient engagement.
- Pricing / Trial
- Enterprise strategy call / quote-based platform and logistics model.
- Use Case in Healthcare
- Monitors patients at home with wearable and connected devices, communication, dashboards, and alarms.
- FDA Approved
- Yes - FDA-cleared Current wearable monitoring devices listed by FDA sources.
- Rating or Market Reputation
- Part of Best Buy Health; Current Health platform available in Epic Toolbox.
- Short Benefits
- Supports care-at-home, logistics, device delivery, engagement, and remote clinical oversight.
- Limitations or Caution
- Requires staffing model, escalation protocols, device support, and patient adherence planning.
- Best Suited For
- Hospital-at-home, chronic care management, virtual care, post-discharge monitoring.
Sources: Remote patient monitoring | Epic Toolbox update | FDA sensor-based device list
Biofourmis Biovitals
FDA: Yes
- Specialized Area
- AI-enabled physiologic monitoring, remote patient management, predictive analytics, and virtual care.
- Pricing / Trial
- Enterprise contracts; public pricing not listed.
- Use Case in Healthcare
- Uses physiologic data from sensors and analytics to support monitoring of patients at home or ambulatory settings.
- FDA Approved
- Yes - Biovitals Analytics Engine received FDA clearance for ambulatory physiologic monitoring.
- Rating or Market Reputation
- Known in remote monitoring and hospital-at-home ecosystem; used with leading care-at-home programs.
- Short Benefits
- Personalized risk signals, remote monitoring workflows, earlier intervention support.
- Limitations or Caution
- Device accuracy, alarms, patient adherence, and staffing workflows must be validated.
- Best Suited For
- Virtual wards, hospital-at-home, chronic disease monitoring, pharma-supported remote care.
Sources: Official | FDA clearance news
Insilico Medicine Pharma.AI
FDA: N/A
- Specialized Area
- Target discovery, molecule generation, clinical trial prediction, scientific AI agents, and drug R&D workflows.
- Pricing / Trial
- Standalone technology access or collaborations; enterprise pricing not public.
- Use Case in Healthcare
- Helps pharma and biotech teams identify targets, design molecules, and prioritize development programs.
- FDA Approved
- Not Applicable - R&D platform, not a clinical diagnostic device.
- Rating or Market Reputation
- High-profile 2026 Lilly partnership reported up to $2.75B; broad attention in AI drug discovery.
- Short Benefits
- May reduce early R&D time, explore more chemical space, and prioritize candidates.
- Limitations or Caution
- AI-discovered drugs still face normal clinical trial risk, safety risk, and regulatory review.
- Best Suited For
- Pharma, biotech, translational research groups, and life sciences investors.
Sources: Official Pharma.AI | 2026 Pharma.AI update | Lilly partnership coverage
Recursion OS
FDA: N/A
- Specialized Area
- AI-native drug discovery and development platform spanning target identification to clinical development.
- Pricing / Trial
- Partnership/collaboration model; not a typical hospital SaaS purchase.
- Use Case in Healthcare
- Uses large biological datasets, automation, and machine learning to discover and advance drug candidates.
- FDA Approved
- Not Applicable - drug discovery platform; individual drug candidates require separate regulatory approval.
- Rating or Market Reputation
- Strong TechBio visibility; partnerships include NVIDIA and Roche/Genentech, with Exscientia combination strengthening platform.
- Short Benefits
- Industrialized experimentation, AI-guided molecule design, large-scale biological insight generation.
- Limitations or Caution
- Scientific promise does not guarantee clinical success or commercial approval.
- Best Suited For
- Pharma, biotech, academic discovery groups, and strategic life-sciences partners.
Sources: Recursion OS | Partners | Exscientia combination
Quick Buyer Checklist
Clinical Safety
Check intended use, evidence, local validation, clinician oversight, fail-safe escalation, and post-deployment monitoring.
Technology Fit
Confirm EHR integration, identity management, audit logs, uptime, cybersecurity, support, and data export rights.
Business Value
Define baseline metrics before purchase: turnaround time, burnout, denials, no-shows, utilization, LOS, or screening rates.
Important Disclaimer
This report is for awareness and educational purposes only. Hospitals must validate regulatory approval, clinical safety, privacy, and compliance before implementation.
Visit https://medihub.app/AI for more details.